Literature DB >> 18162698

The impact of traumatic brain injuries: a global perspective.

Adnan A Hyder1, Colleen A Wunderlich, Prasanthi Puvanachandra, G Gururaj, Olive C Kobusingye.   

Abstract

Traumatic brain injury (TBI), according to the World Health Organization, will surpass many diseases as the major cause of death and disability by the year 2020. With an estimated 10 million people affected annually by TBI, the burden of mortality and morbidity that this condition imposes on society, makes TBI a pressing public health and medical problem. The burden of TBI is manifest throughout the world, and is especially prominent in Low and Middle Income Countries which face a higher preponderance of risk factors for causes of TBI and have inadequately prepared health systems to address the associated health outcomes. Latin America and Sub Saharan Africa demonstrate a higher TBI-related incidence rate varying from 150-170 per 100,000 respectively due to RTIs compared to a global rate of 106 per 100,000. As highlighted in this global review of TBI, there is a large gap in data on incidence, risk factors, sequelae, financial costs, and social impact of TBI. This should be addressed through planning of comprehensive TBI prevention programs in LMICs through well-established surveillance systems. Greater resources for research and prioritized interventions are critical to promote evidence-based policy for TBI.

Entities:  

Mesh:

Year:  2007        PMID: 18162698

Source DB:  PubMed          Journal:  NeuroRehabilitation        ISSN: 1053-8135            Impact factor:   2.138


  438 in total

1.  Short-duration treatment with the calpain inhibitor MDL-28170 does not protect axonal transport in an in vivo model of traumatic axonal injury.

Authors:  Marek Ma; Luchuan Li; Xinran Wang; Diana L Bull; Frances S Shofer; David F Meaney; Robert W Neumar
Journal:  J Neurotrauma       Date:  2012-01-06       Impact factor: 5.269

Review 2.  The "Janus-faced role" of autophagy in neuronal sickness: focus on neurodegeneration.

Authors:  Maria Teresa Viscomi; Marcello D'Amelio
Journal:  Mol Neurobiol       Date:  2012-07-07       Impact factor: 5.590

3.  Calpastatin overexpression protects axonal transport in an in vivo model of traumatic axonal injury.

Authors:  Marek Ma; Frances S Shofer; Robert W Neumar
Journal:  J Neurotrauma       Date:  2012-08-29       Impact factor: 5.269

Review 4.  Regional research priorities in brain and nervous system disorders.

Authors:  Vijayalakshmi Ravindranath; Hoang-Minh Dang; Rodolfo G Goya; Hader Mansour; Vishwajit L Nimgaonkar; Vivienne Ann Russell; Yu Xin
Journal:  Nature       Date:  2015-11-19       Impact factor: 49.962

5.  Neuronal Enriched Extracellular Vesicle Proteins as Biomarkers for Traumatic Brain Injury.

Authors:  Hanuma Kumar Karnati; Joseph H Garcia; David Tweedie; Robert E Becker; Dimitrios Kapogiannis; Nigel H Greig
Journal:  J Neurotrauma       Date:  2018-10-25       Impact factor: 5.269

6.  Nurses' concerns about caring for patients with acute and chronic traumatic brain injury.

Authors:  Tolu O Oyesanya; Barbara J Bowers; Heather R Royer; Lyn S Turkstra
Journal:  J Clin Nurs       Date:  2018-03-24       Impact factor: 3.036

Review 7.  Animal models of traumatic brain injury.

Authors:  Ye Xiong; Asim Mahmood; Michael Chopp
Journal:  Nat Rev Neurosci       Date:  2013-02       Impact factor: 34.870

8.  Suicide, fatal injuries, and other causes of premature mortality in patients with traumatic brain injury: a 41-year Swedish population study.

Authors:  Seena Fazel; Achim Wolf; Demetris Pillas; Paul Lichtenstein; Niklas Långström
Journal:  JAMA Psychiatry       Date:  2014-03       Impact factor: 21.596

Review 9.  Epilepsy related to traumatic brain injury.

Authors:  Asla Pitkänen; Riikka Immonen
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

10.  Abbreviated environmental enrichment confers neurobehavioral, cognitive, and histological benefits in brain-injured female rats.

Authors:  Hannah L Radabaugh; Lauren J Carlson; Darik A O'Neil; Megan J LaPorte; Christina M Monaco; Jeffrey P Cheng; Patricia B de la Tremblaye; Naima Lajud; Corina O Bondi; Anthony E Kline
Journal:  Exp Neurol       Date:  2016-09-28       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.